Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health are now ProPharma Group. Learn more.

Joshua Reilly

Board Member

Joshua Reilly has been involved in principal investing and investment banking since 2008. Prior to Linden, he was a Private Equity Senior Associate at RoundTable Healthcare Partners. Mr. Reilly began his career as an Investment Banking Analyst at William Blair & Co. where he focused on M&A advisory and capital raising transactions for the healthcare sector.

Mr. Reilly holds an AB cum laude in Economics from Harvard College and an MBA with Distinction from the Kellogg School of Management.

Company Blog

March 15, 2019
Assumed Brexit & Batch Control Testing Site In UK
Understanding the European Commission (EC) notice on the European rules for batch control testing… Read More
March 10, 2019
ProPharma Group Announces Acquisition of Southwood Research
Southwood Research is a leading provider of pre-approval regulatory science services to the pharmaceutical… Read More
March 6, 2019
Health Apps and the Requirements Imposed By the Law
Understanding medical apps and necessary considerations based on European regulatory requirements. Read More
More Articles

UPCOMING Events

March 27, 2019
MassBIO Annual Meeting
This year’s Annual Meeting is now the State of Possible Conference where we’ll celebrate what’s poss... Read More
April 01, 2019
ISPE Europe Annual Conference
Join the European pharmaceutical industry’s top decision makers and influencers at the ISPE Europe Annual Co... Read More
April 02, 2019
Future of Health
Meet ProPharma Group at the Future of Health! Future of Health is European largest, hottest and most interact... Read More
All Events
Contact Us